Published on in Vol 9, No 9 (2020): September

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/19456, first published .
Telomerase Activation to Reverse Immunosenescence in Elderly Patients With Acute Coronary Syndrome: Protocol for a Randomized Pilot Trial

Telomerase Activation to Reverse Immunosenescence in Elderly Patients With Acute Coronary Syndrome: Protocol for a Randomized Pilot Trial

Telomerase Activation to Reverse Immunosenescence in Elderly Patients With Acute Coronary Syndrome: Protocol for a Randomized Pilot Trial

Journals

  1. Hoffmann J, Richardson G, Haendeler J, Altschmied J, Andrés V, Spyridopoulos I. Telomerase as a Therapeutic Target in Cardiovascular Disease. Arteriosclerosis, Thrombosis, and Vascular Biology 2021;41(3):1047 View
  2. Ale-Agha N, Jakobs P, Goy C, Zurek M, Rosen J, Dyballa-Rukes N, Metzger S, Greulich J, von Ameln F, Eckermann O, Unfried K, Brack F, Grandoch M, Thielmann M, Kamler M, Gedik N, Kleinbongard P, Heinen A, Heusch G, Gödecke A, Altschmied J, Haendeler J. Mitochondrial Telomerase Reverse Transcriptase Protects From Myocardial Ischemia/Reperfusion Injury by Improving Complex I Composition and Function. Circulation 2021;144(23):1876 View
  3. Barone M, D’Amico F, Rampelli S, Brigidi P, Turroni S. Age-related diseases, therapies and gut microbiome: A new frontier for healthy aging. Mechanisms of Ageing and Development 2022;206:111711 View
  4. Wu W, Du Z, Wu L. Dexmedetomidine attenuates hypoxia‐induced cardiomyocyte injury by promoting telomere/telomerase activity: Possible involvement of ERK1/2‐Nrf2 signaling pathway. Cell Biology International 2022;46(7):1036 View
  5. Díaz-Vesga M, Zúñiga-Cuevas Ú, Ramírez-Reyes A, Herrera-Zelada N, Palomo I, Bravo-Sagua R, Riquelme J. Potential Therapies to Protect the Aging Heart Against Ischemia/Reperfusion Injury. Frontiers in Cardiovascular Medicine 2021;8 View
  6. Liberale L, Badimon L, Montecucco F, Lüscher T, Libby P, Camici G. Inflammation, Aging, and Cardiovascular Disease. Journal of the American College of Cardiology 2022;79(8):837 View
  7. Savchenko A, Tikhonova E, Kudryavtsev I, Kudlay D, Korsunsky I, Beleniuk V, Borisov A. TREC/KREC Levels and T and B Lymphocyte Subpopulations in COVID-19 Patients at Different Stages of the Disease. Viruses 2022;14(3):646 View
  8. Fossel M, Bean J, Khera N, Kolonin M. A Unified Model of Age-Related Cardiovascular Disease. Biology 2022;11(12):1768 View
  9. Bogorodskiy A, Okhrimenko I, Burkatovskii D, Jakobs P, Maslov I, Gordeliy V, Dencher N, Gensch T, Voos W, Altschmied J, Haendeler J, Borshchevskiy V. Role of Mitochondrial Protein Import in Age-Related Neurodegenerative and Cardiovascular Diseases. Cells 2021;10(12):3528 View
  10. Mosevitsky M. Progerin and Its Role in Accelerated and Natural Aging. Molecular Biology 2022;56(2):125 View
  11. Belizário J, Garay-Malpartida M. GROWTH HORMONE, IMMUNOSENESCENCE AND VACCINATION FAILURE IN THE ELDERLY. Clinical Immunology Communications 2023;3:51 View
  12. Loh S, Ekinci Y, Spray L, Jeyalan V, Olin T, Richardson G, Austin D, Alkhalil M, Spyridopoulos I. Fractalkine Signalling (CX3CL1/CX3CR1 Axis) as an Emerging Target in Coronary Artery Disease. Journal of Clinical Medicine 2023;12(14):4821 View
  13. Schuermans A, Nakao T, Uddin M, Hornsby W, Ganesh S, Shadyab A, Liu S, Haring B, Shufelt C, Taub M, Mathias R, Kooperberg C, Reiner A, Bick A, Manson J, Natarajan P, Honigberg M. Age at Menopause, Leukocyte Telomere Length, and Coronary Artery Disease in Postmenopausal Women. Circulation Research 2023;133(5):376 View
  14. Xu J, Zhu G, Zhang H. Causal relationship between telomere length and sepsis: a bidirectional Mendelian randomization study. Scientific Reports 2024;14(1) View
  15. Jiang Y, Li H. The effect of smoking on tumor immunoediting: Friend or foe?. Tobacco Induced Diseases 2024;22(June):1 View

Books/Policy Documents

  1. Nilsson P, Fossel M, Bean J, Khera N. Aging. View